Health Economic Modelling

Health economic modelling uses analytical frameworks to compare the costs and outcomes of different treatments and interventions.  By synthesising clinical, epidemiological and cost data, economic models enable decision-makers to assess the value and affordability of a healthcare innovation.

Rarely can drugs or devices be procured or reimbursed on the strength of clinical evidence alone. Healthcare decision-makers almost always require a structured economic model that demonstrates the value to be gained from an intervention and the expected financial impact of its adoption. This modelling must be rigorous enough to withstand scrutiny from health technology assessment (HTA) bodies and payers. When a model lacks credibility or methodological rigour the consequences are significant: delayed or negative HTA recommendations, failed procurements and missed market access opportunities.

My cost-utility, cost-effectiveness and budget impact projects span multiple therapeutic areas, clinical settings and perspectives: from single-hospital providers to regional health systems or national payers. Each model is fully validated to ensure its accuracy, credibility and relevance to the market in which access is being sought.